Nonmyeloablative conditioning combined with the anti-CD117 antibody briquilimab in older adults with high-risk AML and MDS

Journal:

Blood

Published:

2026-05-28

DOI:

10.1182/blood.2025031858

Affiliations:

8

Authors:

16

Go to article

Institutions	Authors	Share
Jasper, United States of America (USA)	6.500000	0.41
Stanford University, United States of America (USA)	2.500000	0.16
Fred Hutchinson Cancer Center, United States of America (USA)	1.500000	0.09
Huntsman Cancer Institute at the University of Utah (HCI), Utah, United States of America (USA)	1.500000	0.09
Oregon Health and Science University (OHSU), United States of America (USA)	1.000000	0.06
University of Arkansas for Medical Sciences (UAMS), United States of America (USA)	1.000000	0.06
University of California, San Francisco (UCSF), United States of America (USA)	1.000000	0.06
City of Hope, United States of America (USA)	1.000000	0.06

Interested in Oncology and Carcinogenesis?